Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.
Article in Journal of Oncology Pharmacy Practice (May 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
Article in Journal of Drug Assessment (December 2020)
Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension
Article in Autonomic Neuroscience (February 2020)